Nanalysis Announces New Director and Results of AGM
Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) announced the results of its Annual General and Special Meeting of shareholders held on June 26, 2024. All proposed resolutions were approved, including the election of directors and the appointment of Ernst & Young LLP as auditor. The number of directors was set at six, with all nominees elected for a one-year term. Shareholders voted 99.869% in favor of setting the number of directors at six, 99.056% for appointing Ernst & Young, and 98.629% for re-approving the stock option plan.
The Board welcomed Jennifer Stubbs, CFO of FLINT Corp., as a new director. Guido Cloetens stepped down, not standing for re-election. Stubbs brings extensive financial experience from various industries including energy infrastructure and real estate, notably serving at Pembina Pipeline prior to her current role at FLINT Corp.
- All proposed resolutions were approved at the AGM, reflecting strong shareholder support.
- The election results showed high approval rates for director nominees, with percentages ranging from 96.991% to 98.868%.
- Appointment of Ernst & Young LLP as the auditor was approved by 99.056% of shareholders.
- The stock option plan was re-approved by 98.629% of shareholders.
- Jennifer Stubbs, with significant financial and industry experience, joined the Board of Directors.
- Guido Cloetens, a valuable contributor, has stepped down from the Board, potentially leading to a loss of experience and continuity for the company.
Nominees | % For | % Withheld |
Sean Krakiwsky | 96.991 % | 3.009 % |
Martin Burian | 98.868 % | 1.132 % |
Werner Gartner | 98.868 % | 1.132 % |
Michal Okoniewski | 98.868 % | 1.132 % |
Dr. René Lenggenhager | 97.275 % | 2.725 % |
Jennifer Stubbs | 98.819 % | 1.181 % |
Shareholders voted
Corporate Update – Board of Director Changes
The Company is pleased to welcome Ms. Jennifer Stubbs to Nanalysis' Board of Directors with immediate effect following shareholder approval at the Meeting. The Company also announces that Guido Cloetens has stepped down as a director of the Company as he did not stand for re-election at the Meeting. The Board of Directors wishes to sincerely thank Mr. Cloetens for his many valuable contributions to the Company during his time as a director and wishes him well in the future.
Ms. Stubbs currently serves as Chief Financial Officer of FLINT Corp. and was appointed to this role in July 2023. Ms. Stubbs started her career at KPMG in Assurance and went on to hold financial roles in various industries, including engineering, manufacturing, real estate and energy infrastructure. Prior to joining FLINT, Ms. Stubbs was with Pembina Pipeline Corporation for 11 years. She progressed through various financial roles with the organization with her last role as Vice President, Continuous Improvement, which included responsibilities for Internal Audit, oversight and reporting of corporate productivity initiatives and capital project governance. Ms. Stubbs is a Chartered Professional Accountant and holds a Bachelor of Commerce from the University of British Columbia.
About Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA:1N1)
Nanalysis Scientific Corp. in operates two primary business segments: Scientific Equipment and Security Services. Within its Scientific Equipment business is what the Company terms "MRI and NMR for industry". The Company develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The NMReady-60™ was the first full-feature portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The Company has followed-up that initial offering with new products and continues to have a strong innovation pipeline. In 2020, the Company announced the launch of its 100MHz device, the most powerful and most advanced compact NMR device ever brought to market.
The Company's devices are used in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, law enforcement, and more) as well as numerous government and university research labs around the world. The Company continues to exploit new global market opportunities independently and with partners. With its partners, the Company provides scientific equipment sales and maintenance services globally.
In 2022 the Company was awarded a five-year,
Notice regarding Forward Looking Statements and Legal Disclaimer
This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.
View original content to download multimedia:https://www.prnewswire.com/news-releases/nanalysis-announces-new-director-and-results-of-agm-302185975.html
SOURCE Nanalysis Scientific Corp.
FAQ
What were the key resolutions approved at Nanalysis's AGM on June 26, 2024?
Who were the director nominees elected at Nanalysis's AGM 2024?
What percentage of shareholders voted in favor of appointing Ernst & Young LLP as auditor?
Who is the new director added to Nanalysis's Board in June 2024?
Why did Guido Cloetens step down from Nanalysis's Board?
What expertise does Jennifer Stubbs bring to Nanalysis's Board?
